www.fdanews.com/articles/150502-ben-venue-rsquo-s-bedford-plant-resumes-producing-some-generic-injectables
Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables
October 26, 2012
Ben Venue’s Bedford, Ohio, plant — in the news this past year for quality problems — has restarted a handful of production lines to make some of its critical-need drugs available again. Injectable generics such as radiotherapy drug amifostine, muscle relaxant vecuronium, chemotherapy drug gemcitabine and vasodilator phentolamine are once more returning to market shelves.
Generic Line
Generic Line